• Levodopa (L-Dopa) -Zion Pharma

L-Dopa (Levodopa) powder >99%

6,8049,00

L-Dopa (Levodopa) purity over 99%. From European lab.

SKU: levodopa-powder

ACTIVE INGREDIENT: Levodopa >99%

ADDITIONAL INGREDIENTS:

OTHER NAMES: l-DOPA; levodopa; l-3,4-dihydroxyphenylalanine; Dopar; Inbrija;

CAS NUMBER: 59-92-7

ATC CODE: N04BA01

FORMULA: C9H11NO4

MOLAR MASS: 197,190 g·mol−1

ITEM TYPE: Powder

QUANTITY PER PACK: 2 to 20 grams

SERVINGS PER PACK:

SUGGESTED USE:

STORAGE: Store in a cool and dry place. Keep away from direct sunlight and heat.

WARNING: Keep out of reach of children. Do not take this or any other supplement if under the age of 18, pregnant or nursing a baby, or if you have any known or suspected medical conditions, and/or taking prescription drugs or over the counter medications.

DISCLAIMER: Always consult with a qualified health physician before taking any new dietary supplement. This product is not intended to diagnose, treat, cure, or prevent any diseases.

SCOOPS: This product includes a measuring scoop 80 mg

The product is not intended for human use. For laboratory use only.

L-DOPA is the amino acid from which the neurotransmitter dopamine is produced in the brain. In 1936 in India, it was isolated from bean seeds, used in Ayurveda to treat Parkinson’s disease. However, since the use of levodopa was not seen at the time, the discovery went unappreciated. In the 1950s, Swedish neuropharmacologist Arvid Carlsson studied its use in the treatment of Parkinson’s disease, associated with the degeneration of dopaminergic neurons in a part of the brain called the black matter. Twenty years later, its use for this purpose has become widespread. Initially, work was carried out on isolating this amino acid from plant raw materials, but this direction was abandoned when a method for its laboratory synthesis was discovered. To date, levodopa is most commonly used in antiparkinsonian therapy, and work on new drugs consists mainly of improving it – enteral, inhaled, extended-release preparations, etc. are being developed. In 2000, Arvid Carlsson was awarded the Nobel Prize for his research.